Biomerica Inc SEC filings BMRA

Biomerica Inc has 605 filings in SEC EDGAR's recent list, going back to Sep 28, 1995. Its latest annual report, Form 10-K, was filed on Aug 31, 2026 for the period ended May 31, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 15, 2026, covering the quarter ended Aug 31, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (officer or director change). The company's fiscal year ends on May 31.

Biomerica Inc SEC filings
Form Description Filed Period
DEF 14A Proxy statement Oct 16, 2026 Oct 16, 2026
10-Q Quarterly report Oct 15, 2026 Aug 31, 2026
8-K Current report
Officer or director change
Oct 15, 2026 Oct 9, 2026
EFFECT Filing Oct 7, 2026 —
EFFECT Filing Oct 7, 2026 —
10-K/A Amended annual report Sep 28, 2026 May 31, 2026
S-3 Shelf registration Sep 24, 2026 —
S-3 Shelf registration Sep 24, 2026 —
3 Initial insider ownership Sep 10, 2026 Aug 25, 2026
3 Initial insider ownership Sep 8, 2026 Aug 27, 2026
10-K Annual report Aug 31, 2026 May 31, 2026
SCHEDULE 13D Ownership over 5% (active) Aug 28, 2026 —
4 Insider transaction Aug 27, 2026 Aug 26, 2026
4 Insider transaction Aug 27, 2026 Aug 26, 2026
4 Insider transaction Aug 27, 2026 Aug 26, 2026
4 Insider transaction Aug 27, 2026 Aug 26, 2026
4 Insider transaction Aug 27, 2026 Aug 26, 2026
8-K Current report
Material agreement, Unregistered share sale
Aug 26, 2026 Aug 20, 2026
8-K Current report
Material agreement, New debt
Jun 4, 2026 May 29, 2026
10-Q Quarterly report Apr 13, 2026 Feb 28, 2026
S-8 Employee stock plan registration Feb 27, 2026 —
4 Insider transaction Jan 28, 2026 Dec 12, 2025
10-Q Quarterly report Jan 14, 2026 Nov 30, 2025
4 Insider transaction Dec 31, 2025 Dec 12, 2025
4 Insider transaction Dec 31, 2025 Dec 12, 2025
4 Insider transaction Dec 31, 2025 Dec 12, 2025
4 Insider transaction Dec 31, 2025 Dec 12, 2025
4 Insider transaction Dec 31, 2025 Dec 12, 2025
8-K Current report
Shareholder vote results
Dec 16, 2025 Dec 12, 2025
DEFA14A Additional proxy material Oct 23, 2025 —
DEF 14A Proxy statement Oct 20, 2025 Dec 12, 2025
10-Q Quarterly report Oct 14, 2025 Aug 31, 2025
PRE 14A Preliminary proxy statement Oct 9, 2025 Oct 9, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 8, 2025 Oct 7, 2025
10-K/A Amended annual report Sep 26, 2025 May 31, 2025
10-K Annual report Aug 29, 2025 May 31, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 6, 2025 Jun 4, 2025
3 Initial insider ownership Jun 6, 2025 Jun 4, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Apr 16, 2025 Apr 15, 2025
10-Q Quarterly report Apr 14, 2025 Feb 28, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 11, 2025 —
10-Q Quarterly report Jan 14, 2025 Nov 30, 2024
S-8 Employee stock plan registration Dec 20, 2024 —
4 Insider transaction Dec 17, 2024 Dec 13, 2024
4 Insider transaction Dec 17, 2024 Dec 13, 2024
4 Insider transaction Dec 17, 2024 Dec 13, 2024
4 Insider transaction Dec 17, 2024 Dec 13, 2024
4 Insider transaction Dec 17, 2024 Dec 13, 2024
4 Insider transaction Dec 17, 2024 Dec 13, 2024
8-K Current report
Shareholder vote results
Dec 17, 2024 Dec 13, 2024
S-8 Employee stock plan registration Nov 25, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
8-K Current report
Listing notice
Nov 6, 2024 Nov 6, 2024
10-Q Quarterly report Oct 15, 2024 Aug 31, 2024
DEF 14A Proxy statement Sep 30, 2024 Sep 30, 2024
PRE 14A Preliminary proxy statement Sep 20, 2024 Dec 13, 2024
10-K Annual report Aug 28, 2024 May 31, 2024
5 Annual insider ownership Jul 3, 2024 May 31, 2024
8-K Current report
Officer or director change
Jun 28, 2024 Jun 26, 2024
424B5 Prospectus supplement May 10, 2024 —
8-K Current report
Material agreement, Listing notice
May 10, 2024 May 7, 2024
10-Q Quarterly report Apr 12, 2024 Feb 29, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 9, 2024 —
10-Q Quarterly report Jan 16, 2024 Nov 30, 2023
4 Insider transaction Dec 14, 2023 Dec 13, 2023
4 Insider transaction Dec 14, 2023 Dec 13, 2023
4 Insider transaction Dec 14, 2023 Dec 13, 2023
4 Insider transaction Dec 14, 2023 Dec 13, 2023
4 Insider transaction Dec 14, 2023 Dec 13, 2023
4 Insider transaction Dec 14, 2023 Dec 13, 2023
4 Insider transaction Dec 14, 2023 Dec 13, 2023
4 Insider transaction Dec 11, 2023 Dec 7, 2023
4 Insider transaction Dec 11, 2023 Dec 7, 2023
4 Insider transaction Dec 11, 2023 Dec 7, 2023
4 Insider transaction Dec 11, 2023 Dec 7, 2023
4 Insider transaction Dec 11, 2023 Dec 7, 2023
8-K Current report
Shareholder vote results
Dec 11, 2023 Dec 7, 2023
4 Insider transaction Dec 11, 2023 Dec 7, 2023
10-Q Quarterly report Oct 12, 2023 Aug 31, 2023
EFFECT Filing Sep 29, 2023 —
UPLOAD Letter from the SEC Sep 29, 2023 —
CORRESP Letter to the SEC Sep 29, 2023 —
S-3 Shelf registration Sep 28, 2023 —
DEF 14A Proxy statement Sep 27, 2023 Sep 27, 2023
8-K Current report
Regulation FD disclosure
Sep 19, 2023 Sep 15, 2023
3 Initial insider ownership Aug 29, 2023 Aug 28, 2023
8-K Current report
Officer or director change
Aug 28, 2023 Aug 28, 2023
10-K Annual report Aug 25, 2023 May 31, 2023
3 Initial insider ownership Aug 18, 2023 Dec 7, 2022
8-K Current report
Bylaw or fiscal year change
Jul 26, 2023 Jul 24, 2023
5 Annual insider ownership Jul 3, 2023 May 31, 2023
4 Insider transaction May 26, 2023 May 25, 2023
4 Insider transaction May 12, 2023 May 12, 2023
4 Insider transaction May 12, 2023 May 10, 2023
4 Insider transaction May 10, 2023 May 9, 2023
4 Insider transaction May 5, 2023 May 4, 2023
4 Insider transaction May 1, 2023 Apr 27, 2023
4 Insider transaction Apr 27, 2023 Apr 26, 2023
8-K Current report
Regulation FD disclosure
Apr 25, 2023 Apr 25, 2023
10-Q Quarterly report Apr 14, 2023 Feb 28, 2023
4 Insider transaction Apr 10, 2023 Apr 6, 2023
3 Initial insider ownership Mar 9, 2023 Mar 1, 2023
8-K Current report
Material agreement, Regulation FD disclosure
Mar 7, 2023 Mar 3, 2023
424B5 Prospectus supplement Mar 7, 2023 —
424B5 Prospectus supplement Mar 2, 2023 —
424B5 Prospectus supplement Mar 2, 2023 —
8-K Current report
Officer or director change
Mar 2, 2023 Mar 1, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
8-K Current report
Regulation FD disclosure
Feb 7, 2023 Feb 7, 2023
4 Insider transaction Jan 31, 2023 Jan 27, 2023
4 Insider transaction Jan 30, 2023 Jan 26, 2023
4 Insider transaction Jan 26, 2023 Jan 25, 2023
4 Insider transaction Jan 25, 2023 Jan 24, 2023
10-Q Quarterly report Jan 13, 2023 Nov 30, 2022
8-K/A Amended current report
Shareholder vote results
Dec 29, 2022 Dec 7, 2022
8-K Current report
Officer or director change
Dec 16, 2022 Dec 16, 2022
8-K Current report
Officer or director change
Dec 16, 2022 Dec 12, 2022
8-K Current report
Shareholder vote results
Dec 9, 2022 Dec 7, 2022
8-K Current report
Officer or director change
Dec 9, 2022 Dec 7, 2022
8-K Current report
Regulation FD disclosure
Nov 14, 2022 Nov 14, 2022
10-Q Quarterly report Oct 13, 2022 Aug 31, 2022
DEF 14A Proxy statement Sep 27, 2022 Dec 7, 2022
10-K Annual report Aug 29, 2022 May 31, 2022
5 Annual insider ownership Jun 24, 2022 May 31, 2022
8-K Current report
Auditor change
Apr 19, 2022 Apr 19, 2022
10-Q Quarterly report Apr 14, 2022 Feb 28, 2022
SC 13G Ownership over 5% (passive) Feb 14, 2022 —
8-K Current report
Regulation FD disclosure, Other events
Feb 10, 2022 Feb 8, 2022
SC 13G/A Amended ownership over 5% (passive) Feb 4, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 4, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 4, 2022 —
10-Q Quarterly report Jan 12, 2022 Nov 30, 2021
8-K Current report
Results of operations, Other events
Dec 16, 2021 Dec 16, 2021
4 Insider transaction Dec 10, 2021 Dec 9, 2021
4 Insider transaction Dec 10, 2021 Dec 9, 2021
4 Insider transaction Dec 10, 2021 Dec 9, 2021
4 Insider transaction Dec 10, 2021 Dec 9, 2021
4 Insider transaction Dec 10, 2021 Dec 9, 2021
4 Insider transaction Dec 10, 2021 Dec 9, 2021
8-K Current report
Shareholder vote results
Dec 10, 2021 Dec 9, 2021
8-K Current report
Other events
Dec 7, 2021 Dec 2, 2021
10-Q Quarterly report Oct 14, 2021 Aug 31, 2021
10-K/A Amended annual report Oct 14, 2021 May 31, 2021
8-K Current report
Restatement
Sep 30, 2021 Sep 30, 2021
DEF 14A Proxy statement Sep 28, 2021 Dec 9, 2021
10-K Annual report Aug 27, 2021 May 31, 2021
5/A Primary document Jun 28, 2021 May 31, 2021
5 Annual insider ownership Jun 25, 2021 Jun 25, 2021
8-K Current report
Regulation FD disclosure, Other events
Jun 25, 2021 Jun 24, 2021
S-8 Employee stock plan registration May 21, 2021 —
10-Q Quarterly report Apr 14, 2021 Feb 28, 2021
SC 13G Ownership over 5% (passive) Feb 3, 2021 —
SC 13G/A Amended ownership over 5% (passive) Feb 3, 2021 —
SC 13G Ownership over 5% (passive) Feb 3, 2021 —
8-K Current report
Other events
Jan 22, 2021 Jan 22, 2021
424B5 Prospectus supplement Jan 22, 2021 —
SC 13G/A Amended ownership over 5% (passive) Jan 20, 2021 —
10-Q Quarterly report Jan 14, 2021 Nov 30, 2020
8-K Current report
Regulation FD disclosure, Other events
Jan 14, 2021 Jan 12, 2021
4 Insider transaction Dec 11, 2020 Dec 10, 2020
4 Insider transaction Dec 11, 2020 Dec 10, 2020
4 Insider transaction Dec 11, 2020 Dec 10, 2020
4 Insider transaction Dec 11, 2020 Dec 10, 2020
4 Insider transaction Dec 11, 2020 Dec 10, 2020
4 Insider transaction Dec 11, 2020 Dec 10, 2020
4 Insider transaction Dec 11, 2020 Dec 10, 2020
8-K Current report
Shareholder vote results
Dec 11, 2020 Dec 11, 2020
8-K Current report
Officer or director change
Dec 11, 2020 Dec 11, 2020
SC 13G Ownership over 5% (passive) Nov 30, 2020 —
4 Insider transaction Oct 27, 2020 Oct 26, 2020
10-Q Quarterly report Oct 15, 2020 Aug 31, 2020
EFFECT Filing Sep 30, 2020 —
CORRESP Letter to the SEC Sep 28, 2020 —
DEF 14A Proxy statement Sep 25, 2020 Dec 10, 2020
CORRESP Letter to the SEC Sep 11, 2020 —
S-3/A Form s-3/a Sep 11, 2020 —
CORRESP Letter to the SEC Sep 9, 2020 —
3 Initial insider ownership Sep 3, 2020 Sep 3, 2020
3 Initial insider ownership Sep 3, 2020 Sep 3, 2020
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Sep 2, 2020 Aug 27, 2020
8-K Current report
Regulation FD disclosure
Sep 2, 2020 Sep 1, 2020
10-K Annual report Aug 31, 2020 May 31, 2020
UPLOAD Letter from the SEC Jul 28, 2020 —
S-3 Shelf registration Jul 21, 2020 —
8-K Current report
Regulation FD disclosure, Other events
Jun 29, 2020 Jun 29, 2020
8-K Current report
Regulation FD disclosure, Other events
Jun 17, 2020 Jun 16, 2020
8-K Current report
Regulation FD disclosure, Other events
Jun 2, 2020 Jun 1, 2020
8-K Current report
Regulation FD disclosure, Other events
May 11, 2020 May 7, 2020
4 Insider transaction Apr 21, 2020 Apr 17, 2020
10-Q Quarterly report Apr 14, 2020 Feb 29, 2020
8-K Current report
Material agreement, Regulation FD disclosure
Apr 6, 2020 Apr 1, 2020
4 Insider transaction Apr 3, 2020 Apr 1, 2020
8-K Current report
Other events
Mar 20, 2020 Mar 20, 2020
424B5 Prospectus supplement Mar 20, 2020 —
8-K Current report
Other events
Mar 18, 2020 Mar 17, 2020
SC 13D Ownership over 5% (active) Mar 4, 2020 —
4 Insider transaction Mar 2, 2020 Feb 28, 2020
D Filing Feb 27, 2020 —
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Feb 27, 2020 Feb 21, 2020

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Listed as
BMRA (Nasdaq)
Fiscal year ends
May 31
Incorporated in
DE
Headquarters
Irvine, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
73290

Other In Vitro & In Vivo Diagnostic Substances companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.